top of page
Home
About Us
Science
Neurological Indications
Clinical Pipeline
PurPrecision
NeuroLabs
Insights
Careers
Contact
More
Use tab to navigate through the menu items.
News
7-Jul-21
PurMinds Completes Initial Strategic Equity Investment in Israeli Psychedelic Drug Company IMIO Life
Read More
March 8, 2022
PsyCap Recap: PurMinds NeuroPharma
Read More
29-Sep-21
PurMinds: 'A Neuroscience Biopharma Company With A Robust Psychedelic Strategy'
Read More
Insights -
News and featured publications
Featured Publications
Read More
bottom of page